Catalog Home Page

The emperor's new dystrophin: Finding sense in the noise

Wilton, S.D., Veedu, R.N. and Fletcher, S. (2015) The emperor's new dystrophin: Finding sense in the noise. Trends in Molecular Medicine, 21 (7). pp. 417-426.

Link to Published Version: http://dx.doi.org/10.1016/j.molmed.2015.04.006
*Subscription may be required

Abstract

Targeted dystrophin exon removal is a promising therapy for Duchenne muscular dystrophy (DMD); however, dystrophin expression in some reports is not supported by the associated data. As in the account of ‘The Emperor's New Clothes’, the validity of such claims must be questioned, with critical re-evaluation of available data. Is it appropriate to report clinical benefit and induction of dystrophin as dose dependent when the baseline is unclear? The inability to induce meaningful levels of dystrophin does not mean that dystrophin expression as an end point is irrelevant, nor that induced exon skipping as a strategy is flawed, but demands that drug safety and efficacy, and study parameters be addressed, rather than questioning the strategy or the validity of dystrophin as a biomarker.

Publication Type: Journal Article
Murdoch Affiliation: Centre for Comparative Genomics
Publisher: Elsevier BV
Copyright: © 2015 Elsevier Ltd.
URI: http://researchrepository.murdoch.edu.au/id/eprint/27232
Item Control Page Item Control Page